Related Experiment Video
Updated: Nov 1, 2025

Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury
Published on: February 15, 2022
[An overview on acute kidney injury in COVID-19]
Claudia Altobelli1, Emanuela de Pascale1, Gabriella Di Natale1
1A.O.R.N. Ospedali dei Colli - Monaldi, Cotugno, CTO - P.O. Domenico Cotugno, U.O.C. Nefrologia e Dialisi, Napoli, Italy.
Insights
Coronavirus disease 2019 (COVID-19) can cause kidney damage, including acute kidney injury (AKI). Early diagnosis and risk factor assessment are crucial for managing COVID-19 patients with renal complications, though mortality remains high.
Area of Science:
- Nephrology
- Infectious Diseases
- Critical Care Medicine
Background:
- SARS-CoV-2 infection causes COVID-19, frequently associated with renal damage.
- Patients may exhibit urinary alterations like proteinuria and hematuria, with or without reduced renal function.
- Acute kidney injury (AKI) is prevalent in critically ill COVID-19 patients, signifying a poor prognosis.
Purpose of the Study:
- To highlight the occurrence and significance of renal damage in COVID-19 patients.
- To emphasize the multifactorial pathogenesis and clinical presentations of kidney injury during COVID-19.
- To underscore the importance of early AKI diagnosis and risk factor assessment in COVID-19 management.
Main Methods:
- Observational analysis of COVID-19 patient cohorts with renal complications.
- Review of clinical presentations including urinary findings and renal function.
- Assessment of AKI as a prognostic factor and impact on mortality.
Main Results:
- AKI is a common and serious complication in hospitalized COVID-19 patients, particularly in intensive care units.
- COVID-19 associated AKI is linked to elevated in-hospital mortality rates.
- Despite therapeutic interventions, mortality in COVID-19 patients with AKI remains a significant concern.
Conclusions:
- Renal damage, including AKI, is a critical aspect of COVID-19 patient care.
- Prompt identification of AKI and associated risk factors is essential for nephrological intervention.
- COVID-19 AKI represents a dynamic and challenging area requiring ongoing research and therapeutic development.
Abstract:
SARS-CoV-2 infection is responsible for the coronavirus disease 2019 (COVID-19). In the complex scenario of COVID-19, it is also possible to find patients with renal damage. The pathogenesis is multifactorial and not unique, and the clinical presentation may include urinary alterations, such as proteinuria and hematuria, accompanied with reduced renal function, or not. Acute kidney injury (AKI) is not uncommon, especially among critically ill patients hospitalized in intensive care unit. AKI is a negative prognostic factor and is associated with high in-hospital mortality. An early diagnosis of AKI and the assessment of any risk factors allow the nephrologist to implement appropriate therapeutic strategies, such as pharmacological or extracorporeal support. Still, mortality in patients with AKI during COVID-19 remains high. COVID-19 AKI is a quickly evolving field of study.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management

